Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential of mRNA vaccines in cancer nanomedicine and immunotherapy
Shulin Pan, Rangrang Fan, Bo Han, et al.
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 20-31
Closed Access | Times Cited: 18

Showing 18 citing articles:

A translational framework to DELIVER nanomedicines to the clinic
Paul Joyce, Christine Allen, Marı́a José Alonso, et al.
Nature Nanotechnology (2024)
Closed Access | Times Cited: 26
Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
Carole Fournier, Marion Mercey-Ressejac, Valentin Dérangère, et al.
EBioMedicine (2025) Vol. 112, pp. 105543-105543
Open Access | Times Cited: 1
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics
Shivani Makhijani, Gehan M. Elossaily, Satish Rojekar, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 6, pp. 559-565
Closed Access | Times Cited: 5
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
Targeted Reduction-Responsive Nanovehicles for Photodynamic Therapy-Primed Immunotherapy in Melanoma
Chenqian Feng, Lingfeng Zhou, Bo Chen, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101311-101311
Open Access
Nasal mRNA Nanovaccine with Key Activators of Dendritic and MAIT Cells for Effective Against Lung Tumor Metastasis in Mice Model
Ang Li, Xushan Cai, Dong Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 11479-11497
Open Access | Times Cited: 2
Interaction design in mRNA delivery systems
Mengyao Yu, Lixin Lin, Dezhong Zhou, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 413-426
Closed Access | Times Cited: 1
Nanotechnology and Immunetherapy: reduction of hepatotoxicity and anti-antineoplastic efficiency
Irami Araújo-Filho, Amália Cínthia Meneses do Rêgo
JOURNAL OF SURGICAL AND CLINICAL RESEARCH (2024) Vol. 15, Iss. 1, pp. 59-78
Open Access | Times Cited: 1
Recent Developments of Vaccines as a Precision Medicine Approach to Cancer Immunotherapy
Joseph F. Murphy
Cancer Screening and Prevention (2024) Vol. 3, Iss. 2, pp. 113-117
Open Access
Second generation of LNP based mRNA vaccine leads to a T cell–inflamed tumor microenvironment favorable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumor model
Carole Fournier, Marion Mercey-Ressejac, Valentin Dérangère, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
RNA与重大疾病诊疗
Di Huang, Tianying Zhang, Xiaohua Jiang, et al.
Chinese Science Bulletin (Chinese Version) (2024) Vol. 69, Iss. 33, pp. 4824-4844
Closed Access
KPV and RAPA Self‐Assembled into Carrier‐Free Nanodrugs for Vascular Calcification Therapy
Li Zhang, Dongze Li, Yierpani Aierken, et al.
Advanced Healthcare Materials (2024)
Closed Access
Advances in Immune Checkpoint Therapy in Hepatocellular Carcinoma
Yamei Huang, Weiping Yu
British Journal of Hospital Medicine (2024), pp. 1-21
Closed Access
Metal‐organic frameworks‐based nanomedicines to promote cancer immunotherapy: Recent advances and future directions
Chenqian Feng, Xiaoyan Liang, Rangrang Fan, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 4
Open Access
Progress in modifying and delivering mRNA therapies for cancer immunotherapy
Karan Goel, Isha Chawla, Garima Garima, et al.
Advances in immunology (2024)
Closed Access
The Potential of mRNA Vaccines to Fight Against Viruses
Xinyi Wang
Viral Immunology (2024) Vol. 37, Iss. 8, pp. 383-391
Closed Access
Page 1

Scroll to top